Uncategorized
Pulmonary fibrosis biotech Avalyn Pharma files for IPO
A biotech developing inhaled formulations of approved pulmonary fibrosis pills wants to tap the public markets to fund its late-stage work.
Avalyn Pharma submitted its pitch on Wednesday night for a …